Carboprost Tromethamine Market

Carboprost Tromethamine Market Size by Application (Postpartum Hemorrhage Treatment and Pregnancy Abortion), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2024 to 2033

Base Year: 2023 Historical Data: 2020-22
  • Report ID: TBI-14224
  • Published Date: Mar, 2024
  • Pages: 234
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global carboprost tromethamine market was valued at USD 2 billion in 2023 and grew at a CAGR of 4% from 2024 to 2033. The market is expected to reach USD 2.96 billion by 2033. The increasing PPH cases will drive the growth of the global carboprost tromethamine market.

Market Introduction:

Carboprost Tromethamine is primarily used in obstetrics and gynaecology. It acts similarly to naturally occurring prostaglandins, stimulating uterine contractions, and is administered via injection. Its main applications include induction of abortion, management of postpartum haemorrhage, and labour induction. The need for Carboprost Tromethamine arises in obstetric and gynecologic practice when there's a requirement to induce abortion, control postpartum haemorrhage, or stimulate labour. Carboprost Tromethamine provides a non-surgical option for abortion induction, offering a safer alternative in certain cases. Its synthetic nature allows for precise dosing and administration, enhancing its efficacy and safety profile. In induction of abortion, Carboprost Tromethamine is used as part of medical abortion procedures, facilitating the expulsion of the products of conception. In postpartum haemorrhage, it helps control excessive bleeding after childbirth, potentially saving lives by preventing severe blood loss. Additionally, it may be used to induce labour when necessary, aiding in the initiation of childbirth. The benefits of Carboprost Tromethamine include its efficacy in inducing uterine contractions, its non-surgical approach to abortion induction, and its precise dosing capabilities.

Carboprost Tromethamine Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • The U.S. Food and Drug Administration (U.S. FDA) has given Aurobindo Pharma subsidiary Eugia Pharma Specialties final permission to produce and distribute single-dose carboprost tromethamine injection USP 250 mcg/mL vials. The medicine is approved for the treatment of postpartum haemorrhage brought on by uterine atony as well as for the termination of pregnancy between weeks 13 and 20 of gestation. This is the 159th authorized ANDA from Eugia Pharma Specialty Group (EPSG) facilities that produce sterile and oral speciality pharmaceuticals, including eight tentative approvals.

Market Dynamics:

Drivers

The rising incidence of PPH and other pregnancy-related complications – The demand for Carboprost Tromethamine is rising due to increasing incidences of obstetric complications such as uterine atony, placental abnormalities, and coagulation disorders. Advanced maternal age and rising rates of obesity and comorbidities contribute to a higher prevalence of obstetric complications. Additionally, healthcare practices like labour induction and cesarean deliveries increase the risk of complications such as uterine atony and placental abnormalities. Environmental factors such as poor nutrition, sedentary lifestyles, and exposure to pollutants also play a role in developing these conditions. As the incidence of these obstetric complications continues to increase, there is a greater need for interventions like Carboprost Tromethamine to manage potential complications, particularly postpartum haemorrhage (PPH). Therefore, the rising demand for Carboprost Tromethamine is driven by the necessity to address the growing incidence of obstetric complications.

Restraints:

The high cost of carboprost tromethamine The cost of Carboprost Tromethamine poses a significant barrier to access, particularly in low- and middle-income countries and for patients lacking adequate health insurance. Several factors contribute to its high cost, including manufacturing expenses, intellectual property rights, regulatory costs, distribution, and research and development costs. Pharmaceutical companies invest substantial resources in research and development, which are reflected in the medication's pricing. Additionally, patent protection grants companies monopoly control over the sale and distribution of Carboprost Tromethamine, limiting competition and potentially keeping prices elevated. The high cost of Carboprost Tromethamine can restrict access to essential obstetric care, particularly in regions with limited healthcare budgets and resources. Therefore, the high cost of carboprost tromethamine will limit the market’s growth.

Opportunities:

The increasing investments in healthcare infrastructure – Advancements in healthcare infrastructure and improvements in obstetric care have significantly contributed to increased awareness about obstetric care and relevant interventions to prevent maternal morbidity and mortality. With a focus on enhancing maternal health outcomes, healthcare systems worldwide are increasingly adopting standardized protocols and emergency services. The integration of Carboprost Tromethamine into such protocols reflects its recognized efficacy in reducing blood loss and preventing maternal morbidity and mortality associated with PPH. Furthermore, healthcare providers receive training and education on using Carboprost Tromethamine properly. This ensures they are proficient in administering the medication safely and effectively during critical situations, optimizing maternal outcomes. Therefore, as healthcare systems continue to improve and attract investments to enhance infrastructure, they will contribute to the market's growth and development during the forecast period.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global carboprost tromethamine market, with a 43% market revenue share in 2023.

The region has an advanced healthcare infrastructure comprising modern hospitals, clinics, and pharmacies equipped to handle obstetric emergencies. Stringent regulatory oversight by relevant authorities ensures that Carboprost Tromethamine meets rigorous safety and efficacy standards before approval for distribution. North America is home to a robust pharmaceutical industry, with leading companies investing in research, development, and production to meet the demand for obstetric medications. The high demand for obstetric medications in North America, coupled with the accessibility of healthcare services, drives the availability of Carboprost Tromethamine for patients.

North America Region Carboprost Tromethamine Market Share in 2023 - 43%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • Amneal Pharmaceuticals, Inc. has approved four generic injectables for the institutional market. The FDA approved the Abbreviated New Drug Application (ANDA) for dexamethasone sodium phosphate injection (USP 10 mg/mL), azacitidine 100 mg, carboprost tromethamine injection (USP 250 mcg/mL), and atropine sulphate injection (USP 0.5 mg/5 mL).
Application Segment Analysis

The application segment is divided into postpartum haemorrhage treatment and pregnancy abortion. The postpartum haemorrhage segment dominated the market, with a market share of around 75% in 2023. Postpartum haemorrhage (PPH) is a potentially life-threatening complication that occurs when a woman experiences excessive bleeding after giving birth. It is one of the leading causes of maternal mortality worldwide. PPH can occur due to various factors, including uterine atony, placental abnormalities, trauma during childbirth, coagulation disorders, or retained placental tissue. Carboprost Tromethamine is often used to manage PPH due to its potent uterotonic properties. Carboprost Tromethamine stimulates uterine contractions. It is particularly effective in cases of uterine atony. Additionally, Carboprost Tromethamine is used when other first-line interventions have failed to control bleeding effectively. It can be administered intramuscularly or directly into the uterine muscle under medical supervision. Carboprost Tromethamine's efficacy in reducing blood loss and preventing further complications makes it a valuable intervention in managing PPH.

Distribution Channel Segment Analysis

The distribution channel segment is divided into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment dominated the market, with a market share of around 44% in 2023. Hospital pharmacies provide controlled environments conducive to storing medications at the appropriate conditions, ensuring the stability and efficacy of Carboprost Tromethamine. Hospital pharmacies adhere to strict regulatory standards and guidelines, guaranteeing patients receive high-quality and safe medications. Additionally, these channels offer accessibility. Healthcare professionals oversee the distribution process, providing counselling on proper usage and monitoring for adverse reactions, thus ensuring the medication's safe administration. Hospital pharmacies are crucial in ensuring the accessibility, regulatory compliance, and safe distribution of Carboprost Tromethamine.

Some of the Key Market Players:
  • Amneal Pharmaceuticals LLP
  • ANGUS Chemical Company
  • BioSpectra, Inc.
  • ChemScene
  • Dr Reddy's Laboratories Ltd.
  • MANUS AKTTEVA BIOPHARMA LLP
  • Merck KGaA
  • Pfizer
  • Universal Biologicals
  • Woodward Pharma

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2023 USD 2 Billion
Market size value in 2033 USD 2.96 Billion
CAGR (2024 to 2033) 4%
Historical data 2020-2022
Base Year 2023
Forecast 2024-2033
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East and Africa. Furthermore, the regions are further analyzed at the country level.
Segments Application and Distribution Channel

Frequesntly Asked Questions

As per The Brainy Insights, the size of the global carboprost tromethamine market was valued at USD 2 billion in 2023 to USD 2.96 billion by 2033.

Global carboprost tromethamine market is growing at a CAGR of 4% during the forecast period 2024-2033.

The market's growth will be influenced by the rising incidence of PPH and other pregnancy related complications.

The high cost of carboprost tromethamine could hamper the market growth.

Request Table of Content

+1

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the global carboprost tromethamine market based on below mentioned segments:

Global Carboprost Tromethamine Market by Application:

  • Postpartum Hemorrhage Treatment
  • Pregnancy Abortion

Global Carboprost Tromethamine Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Carboprost Tromethamine Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date